Skip to main content
Fig. 3 | Critical Care

Fig. 3

From: Intrapulmonary concentrations of meropenem administered by continuous infusion in critically ill patients with nosocomial pneumonia: a randomized pharmacokinetic trial

Fig. 3

Population and individual predicted meropenem concentrations vs observed meropenem concentrations in the plasma and in ELF. Population (a) and individual (b) predicted meropenem concentrations vs observed concentrations of meropenem in the plasma (a and b, respectively) and in ELF (c and d, respectively). The broken line is the line of identity (observed = predicted concentrations)

Back to article page

Critical Care

ISSN: 1364-8535